Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other financing activities (2017 - 2025)

Historic Other financing activities for Cytosorbents (CTSO) over the last 7 years, with Q3 2025 value amounting to $488000.0.

  • Cytosorbents' Other financing activities changed N/A to $488000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year change of. This contributed to the annual value of $4212.0 for FY2019, which is 9715.38% down from last year.
  • As of Q3 2025, Cytosorbents' Other financing activities stood at $488000.0.
  • In the past 5 years, Cytosorbents' Other financing activities registered a high of $818426.0 during Q1 2025, and its lowest value of $488000.0 during Q3 2025.